|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9,340 KRW | -5.56% |
|
-11.89% | +113.00% |
HLB Therapeutics Co.,Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported negative sales was KRW 0.00043 million compared to sales of KRW 298.28 million a year ago. Net loss was KRW 2,302.16 million compared to KRW 11,353.69 million a year ago.
Basic loss per share from continuing operations was KRW 27.8 compared to KRW 172.86 a year ago. Basic loss per share was KRW 32 compared to KRW 181 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +113.00% | 538M | |
| +20.94% | 72.78B | |
| -1.26% | 24.24B | |
| +5.13% | 8.59B | |
| +8.25% | 8.38B | |
| -19.42% | 8.09B | |
| +5.56% | 4.81B | |
| +16.83% | 4.32B | |
| -1.83% | 4.05B | |
| +26.97% | 3.79B |
HLB THERAPEUTICS CO.,LTD. 